Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy

JACC: Cardiovascular Imaging

Volumn 11, Issue 1, 2018, Pages 48-59

  Nakamori, Shiro ^a   Dohi, Kaoru ^a   Ishida, Masaki ^a   Goto, Yoshitaka ^a   Imanaka Yoshida, Kyoko ^a,b   Omori, Taku ^a   Goto, Itaru ^a   Kumagai, Naoto ^a   Fujimoto, Naoki ^a   Ichikawa, Yasutaka ^a   Kitagawa, Kakuya ^a   Yamada, Norikazu ^a   Sakuma, Hajime ^a   Ito, Masaaki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

collagen volume fraction; diffuse myocardial fibrosis; dilated cardiomyopathy; extracellular space; extracellular volume fraction; native T1 mapping

Indexed keywords

COLLAGEN; GADOTERIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; BOLUS INJECTION; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXTRACELLULAR SPACE; EXTRACELLULAR VOLUME FRACTION; FEMALE; HEART; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE QUALITY; LIMIT OF QUANTITATION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; BIOPSY; CARDIAC MUSCLE; CINE MAGNETIC RESONANCE IMAGING; DIAGNOSTIC IMAGING; FIBROSIS; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARDIOMYOPATHY, DILATED; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 85020838623     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2017.04.006     Document Type: Article

References (33)

1. McCrohon, J.A., Moon, J.C., Prasad, S.K., et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108 (2003), 54–59.
2. Soriano, C.J., Ridocci, F., Estornell, J., Jimenez, J., Martinez, V., De Velasco, J.A., Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 45 (2005), 743–748.
3. Mahrholdt, H., Wagner, A., Judd, R.M., Sechtem, U., Kim, R.J., Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26 (2005), 1461–1474.
4. Assomull, R.G., Prasad, S.K., Lyne, J., et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 (2006), 1977–1985.
5. Wu, K.C., Weiss, R.G., Thiemann, D.R., et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51 (2008), 2414–2421.
6. Gulati, A., Jabbour, A., Ismail, T.F., et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309 (2013), 896–908.
7. Spiewak, M., Malek, L.A., Misko, J., et al. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Eur J Radiol 74 (2010), e149–e153.
8. de Leeuw, N., Ruiter, D.J., Balk, A.H., de Jonge, N., Melchers, W.J., Galama, J.M., Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 14 (2001), 299–306.
9. Iles, L., Pfluger, H., Phrommintikul, A., et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52 (2008), 1574–1580.
10. Flett, A.S., Hayward, M.P., Ashworth, M.T., et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122 (2010), 138–144.
11. Sibley, C.T., Noureldin, R.A., Gai, N., et al. T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. Radiology 265 (2012), 724–732.
12. Ugander, M., Oki, A.J., Hsu, L.Y., et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 33 (2012), 1268–1278.
13. Miller, C.A., Naish, J.H., Bishop, P., et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging 6 (2013), 373–383.
14. Ellims, A.H., Shaw, J.A., Stub, D., et al. Diffuse myocardial fibrosis evaluated by post-contrast T1 mapping correlates with left ventricular stiffness. J Am Coll Cardiol 63 (2014), 1112–1118.
15. de Meester de Ravenstein, C., Bouzin, C., Lazam, S., et al. Histological validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from modified Look-Locker imaging (MOLLI) T1 mapping at 3 T. J Cardiovasc Magn Reson 17 (2015), 1–11.
16. Puntmann, V.O., Voigt, T., Chen, Z., et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. J Am Coll Cardiol Img 6 (2013), 475–484.
17. Bull, S., White, S.K., Piechnik, S.K., et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 99 (2013), 932–937.
18. Lee, S.P., Lee, W., Lee, J.M., et al. Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis. Radiology 274 (2015), 359–369.
19. Moon, J.C., Messroghli, D.R., Kellman, P., et al. Myocardial T1 mapping and extracellular volume quantification: A Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson, 15, 2013, 92.
20. Cerqueira, M.D., Weissman, N.J., Dilsizian, V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002), 539–542.
21. Arheden, H., Saeed, M., Higgins, C.B., et al. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 215 (2000), 520–528.
22. Beliveau, P., Cheriet, F., Anderson, S.A., Taylor, J.L., Arai, A.E., Hsu, L.Y., Quantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlation. Comput Biol Med 65 (2015), 103–113.
23. Whittaker, P., Kloner, R.A., Boughner, D.R., Pickering, J.G., Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 89 (1994), 397–410.
24. Rasband WS. ImageJ, U.S. National Institutes of Health, Bethesda, Maryland 1997–2015. Available at: https://imagej.nih.gov/ij/. Accessed October 10, 2015.
25. Lee, J.J., Liu, S., Nacif, M.S., et al. Myocardial T1 and extracellular volume fraction mapping at 3 tesla. J Cardiovasc Magn Reson, 13, 2011, 75.
26. White, S.K., Sado, D.M., Fontana, M., et al. T1 mapping for myocardial extracellular volume measurement by CMR. J Am Coll Cardiol Img 6 (2013), 955–962.
27. aus dem Siepen, F., Buss, S.J., Messroghli, D., et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 16 (2015), 210–216.
28. Piechnik, S.K., Ferreira, V.M., Lewandowski, A.J., et al. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI. J Cardiovasc Magn Reson, 15, 2013, 13.
29. Liu, A., Wijesurendra, R.S., Francis, J.M., et al. Adenosine stress and rest T1 mapping can differentiate between ischemic, infarcted, remote, and normal myocardium without the need for gadolinium contrast agents. J Am Coll Cardiol Img 9 (2016), 27–36.
30. Sharma, S., Adrogue, J.V., Golfman, L., et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18 (2004), 1692–1700.
31. Kellman, P., Bandettini, W.P., Mancini, C., Hammer-Hansen, S., Hansen, M.S., Arai, A.E., Characterization of myocardial T1-mapping bias caused by intramyocardial fat in inversion recovery and saturation recovery techniques. J Cardiovasc Magn Reson, 17, 2015, 33.
32. Olson, L.J., Edwards, W.D., McCall, J.T., Ilstrup, D.M., Gersh, B.J., Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy. J Am Coll Cardiol 10 (1987), 1239–1243.
33. Puntmann, V.O., Carr-White, G., Jabbour, A., et al. T1-mapping and outcome in nonischemic cardiomyopathy. J Am Coll Cardiol Img 9 (2016), 40–50.